Obatoclax mesilate CAS: 803712-79-0 is a type of medication used to treat cancer. Its chemical name is 8-Guanidino-9-ethyl-7,8-dihydro-7-((4-methylphenyl)methyl)-9H-purin-6(5H)-one mesylate, and its molecular formula is C27H30N8O.CH4O3S. The formula weight is 616.71 g/mol, and its CAS number is 803712-79-0.
Top ten keywords from Google and Synonyms
Synonyms: GX15-070, SPC-071, 8-chloro-6-(2-chloroethyl)-9-methyl-8-aza-6,9-dihydro-7H-purine-5,7-dione mesylate salt
Health Benefits of Obatoclax mesilate Obatoclax mesilate is an important medication for the treatment of cancer. It is a member of a class of drugs known as Bcl-2 inhibitors, which are designed to target a protein called Bcl-2 that is known to play a role in the development and survival of cancer cells. Obatoclax mesilate works by triggering apoptosis in cancer cells, which is the process by which cells die naturally.
Potential Effects of Obatoclax mesilate Obatoclax mesilate has shown promising results in the treatment of various types of cancer, including small cell lung cancer, leukemia, and lymphoma. It has also been shown to enhance the effects of chemotherapy in cancer patients.
Product Mechanism Obatoclax mesilate works by inhibiting a protein called Bcl-2 that is known to play a role in the development and survival of cancer cells. By inhibiting the activity of Bcl-2, obatoclax mesilate triggers apoptosis in cancer cells, which is the process by which cells die naturally. This process leads to the elimination of cancer cells and ultimately leads to the treatment of cancer.
Safety and Side Effects As with any medication, there are potential side effects and risks associated with using obatoclax mesilate. Common side effects include nausea, vomiting, and fatigue. Other less common side effects can occur, including skin rash, fever, and confusion. It may also cause birth defects, which is why it shouldn't be taken by women who are pregnant or trying to become pregnant.
Dosing Information The recommended dose of obatoclax mesilate varies depending on the specific condition being treated, the patient's health status, and other factors. Patients should follow their doctor's instructions carefully and take the medication as prescribed to achieve the best results.
Conclusion Obatoclax mesilate is an important medication for the treatment of cancer. It is a member of a class of drugs known as Bcl-2 inhibitors, which are designed to target a protein called Bcl-2 that is known to play a role in the development and survival of cancer cells. Obatoclax mesilate works by triggering apoptosis in cancer cells, which is the process by which cells die naturally. Patients who are considering using obatoclax mesilate should talk to their doctor about whether it is the right treatment option for them, and carefully weigh the benefits and risks. With proper medical supervision, obatoclax mesilate may offer hope for patients suffering from this life-threatening disease.
